439 related articles for article (PubMed ID: 31364446)
21. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
23. Differential Effects of the Interaction Between the Education and APOE ε4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients.
Kang DW; Wang SM; Na HR; Lee CU; Baek IH; Lim HK
Curr Alzheimer Res; 2020; 17(11):1023-1032. PubMed ID: 33372875
[TBL] [Abstract][Full Text] [Related]
24. When time's arrow doesn't bend: APOE-ε4 influences episodic memory before old age.
Eich TS; Tsapanou A; Stern Y
Neuropsychologia; 2019 Oct; 133():107180. PubMed ID: 31473197
[TBL] [Abstract][Full Text] [Related]
25. Subclinical Compromise in Cardiac Strain Relates to Lower Cognitive Performances in Older Adults.
Kresge HA; Khan OA; Wagener MA; Liu D; Terry JG; Nair S; Cambronero FE; Gifford KA; Osborn KE; Hohman TJ; Pechman KR; Bell SP; Wang TJ; Carr JJ; Jefferson AL
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440034
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E and Its Association With Cognitive Change and Modification of Treatment Effects of Vitamin D3 and Omega-3s on Cognitive Change: Results From the In-Clinic Subset of a Randomized Clinical Trial.
Vyas CM; Kang JH; Mischoulon D; Cook NR; Reynolds Iii CF; Chang G; Mora S; De Vivo I; Manson JE; Okereke OI
J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 37952113
[TBL] [Abstract][Full Text] [Related]
27. Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample.
Paradela RS; Justo AFO; Paes VR; Leite REP; Pasqualucci CA; Grinberg LT; Naslavsky MS; Zatz M; Nitrini R; Jacob-Filho W; Suemoto CK
Acta Neuropathol Commun; 2023 Dec; 11(1):205. PubMed ID: 38115150
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
29. APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.
Moore AM; Mahoney E; Dumitrescu L; De Jager PL; Koran MEI; Petyuk VA; Robinson RA; Ruderfer DM; Cox NJ; Schneider JA; Bennett DA; Jefferson AL; Hohman TJ
Neurobiol Aging; 2020 Mar; 87():18-25. PubMed ID: 31791659
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of the APOE genotype on brain function across the lifespan.
Filippini N; Ebmeier KP; MacIntosh BJ; Trachtenberg AJ; Frisoni GB; Wilcock GK; Beckmann CF; Smith SM; Matthews PM; Mackay CE
Neuroimage; 2011 Jan; 54(1):602-10. PubMed ID: 20705142
[TBL] [Abstract][Full Text] [Related]
32. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
33. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
[TBL] [Abstract][Full Text] [Related]
34. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.
Burkhardt MS; Foster JK; Clarnette RM; Chubb SA; Bruce DG; Drummond PD; Martins RN; Yeap BB
J Clin Endocrinol Metab; 2006 Mar; 91(3):1168-72. PubMed ID: 16368754
[TBL] [Abstract][Full Text] [Related]
35. Association of
GoodSmith MS; Wroblewski KE; Schumm LP; McClintock MK; Pinto JM
Neurology; 2023 Sep; 101(13):e1341-e1350. PubMed ID: 37495381
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension.
Hajjar I; Sorond F; Lipsitz LA
J Am Geriatr Soc; 2015 Feb; 63(2):276-81. PubMed ID: 25688603
[TBL] [Abstract][Full Text] [Related]
37. Associations of Apolipoprotein E ε4 Genotype and Ball Heading With Verbal Memory in Amateur Soccer Players.
Hunter LE; Freudenberg-Hua Y; Davies P; Kim M; Lipton RB; Stewart WF; Srinivasan P; Hu S; Lipton ML
JAMA Neurol; 2020 Apr; 77(4):419-426. PubMed ID: 31985774
[TBL] [Abstract][Full Text] [Related]
38. Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.
Durazzo TC; Mattsson N; Weiner MW;
Nicotine Tob Res; 2016 Feb; 18(2):204-11. PubMed ID: 25847292
[TBL] [Abstract][Full Text] [Related]
39. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
40. The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.
Nebes RD; Pollock BG; Perera S; Halligan EM; Saxton JA
Am J Geriatr Pharmacother; 2012 Jun; 10(3):185-92. PubMed ID: 22534472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
